At a time when pharmaceutical companies face increasing price pressures around the globe from key payers, including public and government insurance systems, reducing operational expenses is a major driver of outsourcing pharmaceutical manufacturing to CDMOs. Also, an increasing number of pharmaceutical companies are refocusing on their core capabilities and strengths, leading to divestments of in-house manufacturing capacities in some areas and to a gro Market Analysis and Insights: Global CMO/CDMO Market The global CMO/CDMO market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CMO/CDMO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CMO/CDMO market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CMO/CDMO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CMO/CDMO market. Global CMO/CDMO Scope and Market Size CMO/CDMO market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CMO/CDMO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Development API production Formulation Segment by Application Pharmaceutical Industry Biotechnology Other By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Recipharm AMRI3 Patheon Aenova Catalent Amatsigroup WuXi PharmaTech Strides Shasun Piramal Siegfried
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global CMO/CDMO Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Development 1.2.3 API production 1.2.4 Formulation 1.3 Market by Application 1.3.1 Global CMO/CDMO Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Pharmaceutical Industry 1.3.3 Bio
